Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation, 50948-50950 [2014-20201]
Download as PDF
<![CDATA[
50948
Federal Register / Vol. 79, No. 165 / Tuesday, August 26, 2014 / Notices
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 27, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on June 6,
2014, Chemtos, LLC, 14101 W. Highway
290, Building 2000B, Austin, Texas
78737–9331, applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
DATES:
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Etorphine HCI (9059) ...................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
VerDate Mar<15>2010
21:48 Aug 25, 2014
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 232001
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Meperidine intermediate-C (9234)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Dihydroetorphine (9334) ...............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Racemethorphan (9732) ..............
Racemorphan (9733) ...................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers for use as reference
standards.
Dated: August 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–20195 Filed 8–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 27, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
DATES:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on June 9,
2014, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock,
Texas 78665–2402, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled substance
3-Fluoro-N-methylcathinone
(3–
FMC) (1233).
Cathinone (1235) ..........................
Methcathinone (1237) ..................
4-Fluoro-N-methylcathinone
(4–
FMC) (1238).
Pentedrone
(amethylaminovalerophenone)
(1246).
Mephedrone
(4-Methyl-Nmethylcathinone) (1248).
4-Methyl-N-ethylcathinone
(4–
MEC) (1249).
Naphyrone (1258) ........................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Fenethylline (1503) .......................
Aminorex (1585) ...........................
4-Methylaminorex (cis isomer)
(1590).
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
JWH–250
(1-Pentyl-3-(2methoxyphenylacetyl)
indole)
(6250).
SR–18
and
RCS–8
(1Cyclohexylethyl-3-(2methoxyphenylacetyl)
indole)
(7008).
5-Flouro-UR–144 and XLR11 [1(5-Fluoro-pentyl) 1–H-indol-3yl](2,2,3,3tetramethylcyclopropyl)
methanone (7011).
AB–FUBINACA
(N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(4fluorobenzyl)-1H-indazole-3carboxamide) (7012).
JWH–019
(1-Hexyl-3-(1-naphthoyl)indole) (7019).
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3carboxamide) (7035).
APINACA and AKB48 N-(1Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048).
JWH–081
(1-Pentyl-3-(1-(4methoxynaphthoyl)
indole)
(7081).
E:\FR\FM\26AUN1.SGM
26AUN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
50949
Federal Register / Vol. 79, No. 165 / Tuesday, August 26, 2014 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
SR–19 and RCS–4 (1-Pentyl-3[(4methoxy)-benzoyl]
indole
(7104).
JWH–018 (also known as AM678)
(1-Pentyl-3-(1-naphthoyl)indole)
(7118).
JWH–122 (1-Pentyl-3-(4-methyl-1naphthoyl) indole) (7122).
UR–144
(1-Pentyl-1H-indol-3yl)(2,2,3,3tetramethylcyclopropyl)methanone (7144).
JWH–073
(1-Butyl-3-(1-naphthoyl)indole) (7173).
JWH–200
(1-[2-(4Morpholinyl)ethyl]-3-(1-naphthoyl)indole) (7200).
AM–2201 (1-(5-Fluoropentyl)-3-(1naphthoyl) indole) (7201).
JWH–203
(1-Pentyl-3-(2chlorophenylacetyl)
indole)
(7203).
PB–22 (Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate) (7222).
5F–PB–22 (Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3carboxylate) (7225).
Alpha-ethyltryptamine (7249) .......
CP–47,497
(5-(1,1Dimethylheptyl)-2-[(1R,3S)-3hydroxycyclohexyl-phenol)
(7297).
CP–47,497 C8 Homologue (5(1,1-Dimethyloctyl)-2-[(1R,3S)
3-hydroxycyclohexyl-phenol)
(7298).
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine (2C–
T–7) (7348).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Parahexyl (7374) ..........................
Mescaline (7381) ..........................
2-(4-Ethylthio-2,5dimethoxyphenyl) ethanamine
(2C–T–2) (7385).
3,4,5–Trimethoxyamphetamine
(7390).
4–Bromo–2,5–
dimethoxyamphetamine (7391).
4–Bromo–2,5–
dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
JWH–398 (1-Pentyl-3-(4-chloro-1naphthoyl) indole (7398).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
VerDate Mar<15>2010
21:48 Aug 25, 2014
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 232001
Controlled substance
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
5-Methoxy-N–Ndimethyltryptamine (7431).
Alpha-methyltryptamine (7432) ....
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Ethyl-1-phenylcyclohexylamine
(7455).
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
N-Benzylpiperazine (7493) ...........
4-Methylalphapyrrolidinopropiophenone
(4-mePPP) (7498).
2-(2,5-Dimethoxy-4-methylphenyl)
ethanamine (2C–D) (7508).
2-(2,5-Dimethoxy-4-ethylphenyl)
ethanamine (2C–E) (7509).
2-(2,5-Dimethoxyphenyl)
ethanamine (2C–H) (7517).
2-(4-lodo-2,5-dimethoxyphenyl)
ethanamine (2C–I) (7518).
2-(4-Chloro-2,5-dimethoxyphenyl)
ethanamine (2C–C) (7519).
2-(2,5-Dimethoxy-4-nitro-phenyl)
ethanamine (2C–N) (7521).
2-(2,5-Dimethoxy-4-(n)propylphenyl) ethanamine (2C–
P) (7524).
2-(4-Isopropylthio)-2,5dimethoxyphenyl) ethanamine
(2C–T–4) (7532).
MDPV
(3,4Methylenedioxypyrovalerone)
(7535).
2-(4-bromo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)
ethanamine
(25B–NBOMe)
(7536).
2-(4-chloro-2,5-dimethoxyphenyl)N-(2-methoxybenzyl)
ethanamine
(25C–NBOMe)
(7537).
2-(4-iodo-2,5-dimethoxyphenyl)-N(2-methoxybenzyl) ethanamine
(25I–NBOMe) (7538).
Methylone (3,4-Methylenedioxy-Nmethylcathinone) (7540).
Butylone (7541) ............................
Pentylone (7542) ..........................
alpha-pyrrolidinopentiophenone
(a-PVP) (7545).
alpha-pyrrolidinobutiophenone (aPBP) (7546).
AM–694 (1-(5-Fluoropentyl)-3-(2iodobenzoyl) indole) (7694).
Acetyldihydrocodeine (9051) ........
Benzylmorphine (9052) ................
Codeine-N-oxide (9053) ...............
Desomorphine (9055) ...................
Codeine methylbromide (9070) ....
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Controlled substance
Hydromorphinol (9301) .................
Methyldesorphine (9302) ..............
Methyldihydromorphine (9304) .....
Morphine methylbromide (9305) ..
Morphine methylsulfonate (9306)
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Pholcodine (9314) ........................
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Dipipanone (9622) ........................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Trimeperidine (9646) ....................
Phenomorphan (9647) .................
1-Methyl-4-phenyl-4propionoxypiperidine (9661).
Tilidine (9750) ...............................
Para-Fluorofentanyl (9812) ..........
3-Methylfentanyl (9813) ................
Alpha-methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-methylthiofentanyl (9832) ...
3-Methylthiofentanyl (9833) ..........
Thiofentanyl (9835) ......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
1Piperidinocyclohexanecarbonitrile (8603).
Alphaprodine (9010) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Meperidine intermediate-C (9234)
Metazocine (9240) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
E:\FR\FM\26AUN1.SGM
26AUN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
50950
Federal Register / Vol. 79, No. 165 / Tuesday, August 26, 2014 / Notices
Controlled substance
Schedule
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Racemethorphan (9732) ..............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to their
customers.
Dated: August 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–20201 Filed 8–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: PCASNanosyn, LLC
PCAS-Nanosyn, LLC applied
to be registered as a manufacturer of
certain basic classes of narcotic and
non-narcotic controlled substances. The
DEA grants PCAS-Nanosyn, LLC
registration as a manufacturer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated April 21, 2014, and published in
the Federal Register on April 30, 2014,
79 FR 24452, PCAS-Nanosyn, LLC,
3331–B Industrial Drive, Santa Rosa,
California 95403, applied to be
registered as a manufacturer of certain
basic classes of narcotic or non-narcotic
controlled substances. No comments or
objections have been received.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
PCAS-Nanosyn, LLC to manufacture the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
21:48 Aug 25, 2014
Jkt 232001
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Phencyclidine (7471) ....................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
comments or objections have been
received.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
Patheon Pharmaceuticals, Inc., to
manufacture the basic class of this
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of Gamma Hydroxybutyric
Acid (2010), a basic class of controlled
substance listed in schedule I.
The company plans to manufacture
the listed controlled substance for
distribution to its customers.
Dated: August 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–20198 Filed 8–25–14; 8:45 am]
Dated: August 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Notice of registration.
SUMMARY:
Controlled substance
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of controlled substances
only in bulk form.
Drug Enforcement Administration
ACTION:
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
narcotic and non-narcotic controlled
substances listed:
BILLING CODE 4410–09–P
[FR Doc. 2014–20196 Filed 8–25–14; 8:45 am]
DEPARTMENT OF LABOR
BILLING CODE 4410–09–P
Office of the Secretary
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Patheon
Pharmaceuticals, Inc.
ACTION:
Notice of registration.
Patheon Pharmaceuticals,
Inc., applied to be registered as a
manufacturer of a certain basic class of
controlled substance. The DEA grants
Patheon Pharmaceuticals, Inc.,
registration as a manufacturer of the
controlled substance.
SUPPLEMENTARY INFORMATION: By notice
dated April 21, 2014, and published in
the Federal Register on April 28, 2014,
79 FR 23373, Patheon Pharmaceuticals,
Inc., 2110 E. Galbraith Road, Cincinnati,
Ohio 45237, applied to be registered as
a manufacturer of a certain basic class
of non-narcotic controlled substance. No
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Fire
Protection in Shipyard Employment
Standard
ACTION:
Notice.
The Department of Labor
(DOL) is submitting the Occupational
Safety and Health Administration
(OSHA) sponsored information
collection request (ICR) titled, ‘‘Fire
Protection in Shipyard Employment
Standard,’’ to the Office of Management
and Budget (OMB) for review and
approval for continued use, without
change, in accordance with the
Paperwork Reduction Act of 1995
(PRA), 44 U.S.C. 3501 et seq. Public
comments on the ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before September 25, 2014.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
SUMMARY:
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 79, Number 165 (Tuesday, August 26, 2014)]
[Notices]
[Pages 50948-50950]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20201]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application:
Cerilliant Corporation
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before October 27, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the
Controlled Substances Act to the Administrator of the Drug Enforcement
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all
necessary functions with respect to the promulgation and implementation
of 21 CFR part 1301, incident to the registration of manufacturers, of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR pt. 0, subpt. R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on June
9, 2014, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock,
Texas 78665-2402, applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC) (1233).. I
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
4-Fluoro-N-methylcathinone (4-FMC) (1238).. I
Pentedrone ([alpha]- I
methylaminovalerophenone) (1246).
Mephedrone (4-Methyl-N-methylcathinone) I
(1248).
4-Methyl-N-ethylcathinone (4-MEC) (1249)... I
Naphyrone (1258)........................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Fenethylline (1503)........................ I
Aminorex (1585)............................ I
4-Methylaminorex (cis isomer) (1590)....... I
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) I
indole) (6250).
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2- I
methoxyphenylacetyl) indole) (7008).
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- I
pentyl) 1-H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl) methanone (7011).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide) (7012).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) I
(7019).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide) (7035).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- I
1H-indazole-3-carboxamide (7048).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) I
indole) (7081).
[[Page 50949]]
SR-19 and RCS-4 (1-Pentyl-3[(4-methoxy)- I
benzoyl] indole (7104).
JWH-018 (also known as AM678) (1-Pentyl-3- I
(1-naphthoyl)indole) (7118).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) I
indole) (7122).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- I
tetramethylcyclopropyl)methanone (7144).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) I
(7173).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- I
naphthoyl)indole) (7200).
AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) I
indole) (7201).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) I
indole) (7203).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I
carboxylate) (7222).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- I
1H-indole-3-carboxylate) (7225).
Alpha-ethyltryptamine (7249)............... I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- I
[(1R,3S)-3-hydroxycyclohexyl-phenol)
(7297).
CP-47,497 C8 Homologue (5-(1,1- I
Dimethyloctyl)-2-[(1R,3S) 3-
hydroxycyclohexyl-phenol) (7298).
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (2C-T-7) (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Parahexyl (7374)........................... I
Mescaline (7381)........................... I
2-(4-Ethylthio-2,5-dimethoxyphenyl) I
ethanamine (2C-T-2) (7385).
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) I
indole (7398).
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
Alpha-methyltryptamine (7432).............. I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)... I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
N-Benzylpiperazine (7493).................. I
4-Methyl-alphapyrrolidinopropiophenone (4- I
mePPP) (7498).
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine I
(2C-D) (7508).
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine I
(2C-E) (7509).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) I
(7517).
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine I
(2C-I) (7518).
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine I
(2C-C) (7519).
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine I
(2C-N) (7521).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) I
ethanamine (2C-P) (7524).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) I
ethanamine (2C-T-4) (7532).
MDPV (3,4-Methylenedioxypyrovalerone) I
(7535).
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25B-NBOMe)
(7536).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25C-NBOMe)
(7537).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25I-NBOMe)
(7538).
Methylone (3,4-Methylenedioxy-N- I
methylcathinone) (7540).
Butylone (7541)............................ I
Pentylone (7542)........................... I
alpha-pyrrolidinopentiophenone ([alpha]- I
PVP) (7545).
alpha-pyrrolidinobutiophenone ([alpha]-PBP) I
(7546).
AM-694 (1-(5-Fluoropentyl)-3-(2- I
iodobenzoyl) indole) (7694).
Acetyldihydrocodeine (9051)................ I
Benzylmorphine (9052)...................... I
Codeine-N-oxide (9053)..................... I
Desomorphine (9055)........................ I
Codeine methylbromide (9070)............... I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Hydromorphinol (9301)...................... I
Methyldesorphine (9302).................... I
Methyldihydromorphine (9304)............... I
Morphine methylbromide (9305).............. I
Morphine methylsulfonate (9306)............ I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Acetylmethadol (9601)...................... I
Allylprodine (9602)........................ I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Betacetylmethadol (9607)................... I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Dipipanone (9622).......................... I
Hydroxypethidine (9627).................... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Trimeperidine (9646)....................... I
Phenomorphan (9647)........................ I
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
Tilidine (9750)............................ I
Para-Fluorofentanyl (9812)................. I
3-Methylfentanyl (9813).................... I
Alpha-methylfentanyl (9814)................ I
Acetyl-alpha-methylfentanyl (9815)......... I
Beta-hydroxyfentanyl (9830)................ I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Alpha-methylthiofentanyl (9832)............ I
3-Methylthiofentanyl (9833)................ I
Thiofentanyl (9835)........................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Phenmetrazine (1631)....................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Nabilone (7379)............................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
1-Piperidinocyclohexanecarbonitrile (8603). II
Alphaprodine (9010)........................ II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Meperidine intermediate-A (9232)........... II
Meperidine intermediate-B (9233)........... II
Meperidine intermediate-C (9234)........... II
Metazocine (9240).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
[[Page 50950]]
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Racemethorphan (9732)...................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Carfentanil (9743)......................... II
Tapentadol (9780).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to their customers.
Dated: August 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-20201 Filed 8-25-14; 8:45 am]
BILLING CODE 4410-09-P
